共 476 条
- [1] Cheng AL(2009)Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 25-34
- [2] Kang YK(2008)Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378-390
- [3] Chen Z(2007)Detection and characterization of tumor hypoxia using pO Antioxid Redox Signal 9 1221-1235
- [4] Tsao CJ(2010) histography Mol Cells 29 435-442
- [5] Qin S(2005)HIF-1 and HIF-2 transcription factors-similar but not identical World J Gastroenterol 11 1705-1708
- [6] Kim JS(2013)Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival BMC Cancer 13 108-5472
- [7] Luo R(2011)Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxiainducible factor — 1α in hepatocellular carcinoma Clin Cancer Res 17 5463-5094
- [8] Feng J(2009)Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1alpha, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma Cancer 115 5084-1033
- [9] Ye S(2010)Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death World J Surg 34 1028-11270
- [10] Yang TS(2006)Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma Cancer Res 66 11263-3182